This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by AVGERINOS, P. C. Articles by CUTLER, G. B. Search for Related Content PubMed PubMed Citation Articles by AVGERINOS, P. C. Articles by CUTLER, G. B., JR

The Corticotropin-Releasing Hormone Test in the Postoperative Evaluation of Patients with Cushing's Syndrome

Developmental Endocrinology Branch, National Institute of Child Health and Human Development, (P.C.A., G.P.C., L.K.N., D.L.L., G.B.C.), and the Clinical Neurosurgery Section, the Surgical Neurology Branch, NINCDS (E.H.O.), National Institutes of Health Bethesda, Maryland 20892

Address requests for reprints to: Gordon B. Cutler, Jr, M.D., National Institutes of Health, Building 10, Room 10N262, Bethesda, Maryland 20892.

After surgical cure of Cushing's syndrome most patients develop transient secondary adrenal insufficiency that lasts for approximately 1 yr. Since ACTH-secreting pituitary adenomas generally respond to ovine CRH (oCRH), we tested the hypothesis that an early postoperative response to oCRH may indicate the presence of residual pituitary tumor and, therefore, predict recurrence. We also assessed the usefulness of oCRH for monitoring the recovery of the hypothalamic-pituitary-adrenal axis and for clarifying the pathophysiology of this condition.

Thirty-four patients cured of Cushing's syndrome (29 with Cushing's disease, 3 with adrenal adenomas, and 2 with the ectopic ACTH syndrome) had an evening oCRH test 1-2 weeks after surgery. Nine patients (6 with Cushing's disease, 2 with adrenal adenomas, and 1 with the ectopic ACTH syndrome) participated in a longitudinal evaluation and had repeated oCRH and 1-h ACTH tests at 2-month intervals for a year after surgery. Patients were considered to be cured on the basis of at least 3 subnormal urinary [<20 µg/24 h (<55 nmol/day)] or morning plasma cortisol levels [0600-0900 h; <6 µg/dL (<170 nmol/L)] in the first 2 weeks after surgery.

The plasma ACTH and cortisol responses to oCRH in the early postoperative period were subnormal in 23 and normal in 6 patients with Cushing's disease. Three patients developed recurrent Cushing's disease (3, 3, and 23 months after transsphenoidal surgery). All 3 were among the 6 who had a normal early postoperative response to oCRH. All of the 23 patients who had a subnormal response to oCRH in the early postoperative period have remained in remission for an average followup period of 14 months (6-42 months). Thus, the recurrence rate was significantly greater in patients with normal oCRH tests in the early postoperative period (P < 0.001, by ² analysis).

Surgically cured patients with adrenal adenomas or ectopic ACTH secretion also had subnormal plasma ACTH and cortisol responses to oCRH during the early postoperative period. During longitudinal evaluation for 12 months after surgery, the ACTH and cortisol responses to oCRH increased progressively (regardless of the cause of Cushing's syndrome). Cortisol responses to oCRH correlated significantly with the cortisol responses to exogenous ACTH (r = 0.89; P < 0.00001).

We conclude that most patients with Cushing's syndrome have suppressed responses to oCRH during the early postoperative period. A normal early postoperative response in the patients with Cushing's disease may identify a subgroup of patients who are at increased risk of recurrence.

Address all other correspondence to: Peter C. Avgerinos, Kaplanon 10, Athens 10680, Greece.

Received December 29, 1986.

This article has been cited by other articles:

				M. Losa, R. Bianchi, R. Barzaghi, M. Giovanelli, and P. Mortini Persistent Adrenocorticotropin Response to Desmopressin in the Early Postoperative Period Predicts Recurrence of Cushing's Disease J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3322 - 3328. [Abstract] [Full Text] [PDF]

				C. A. Carrasco, J. Coste, L. Guignat, L. Groussin, M. A. Dugue, S. Gaillard, X. Bertagna, and J. Bertherat Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing's Disease J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4728 - 4734. [Abstract] [Full Text] [PDF]

				G. Arnaldi, A. Angeli, A. B. Atkinson, X. Bertagna, F. Cavagnini, G. P. Chrousos, G. A. Fava, J. W. Findling, R. C. Gaillard, A. B. Grossman, et al. Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5593 - 5602. [Abstract] [Full Text] [PDF]

				A. J. Cleare The Neuroendocrinology of Chronic Fatigue Syndrome Endocr. Rev., April 1, 2003; 24(2): 236 - 252. [Abstract] [Full Text] [PDF]

				J. Newell-Price, D. G. Morris, W. M. Drake, M. Korbonits, J. P. Monson, G. M. Besser, and A. B. Grossman Optimal Response Criteria for the Human CRH Test in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1640 - 1645. [Abstract] [Full Text] [PDF]

				A. J. Cleare, J. Miell, E. Heap, S. Sookdeo, L. Young, G. S. Malhi, and V. O'Keane Hypothalamo-Pituitary-Adrenal Axis Dysfunction in Chronic Fatigue Syndrome, and the Effects of Low-Dose Hydrocortisone Therapy J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3545 - 3554. [Abstract] [Full Text] [PDF]

				C. Invitti, F. P. Giraldi, M. De Martin, and F. Cavagnini Diagnosis and Management of Cushing's Syndrome: Results of an Italian Multicentre Study J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 440 - 448. [Abstract] [Full Text]

				D. J. Devoe, W. L. Miller, F. A. Conte, S. L. Kaplan, M. M. Grumbach, S. M. Rosenthal, C. B. Wilson, and S. E. Gitelman Long-Term Outcome in Children and Adolescents after Transsphenoidal Surgery for Cushing's Disease J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3196 - 3202. [Abstract] [Full Text] [PDF]

				D. Michelson, E. Galliven, L. Hill, M. Demitrack, G. Chrousos, and P. Gold Chronic Imipramine Is Associated with Diminished Hypothalamic-Pituitary-Adrenal Axis Responsivity in Healthy Humans J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2601 - 2606. [Abstract] [Full Text] [PDF]

				G. Cizza, A. J. Lotsikas, J. Licinio, P. W. Gold, and G. P. Chrousos Plasma Leptin Levels Do not Change in Patients with Cushing's Disease Shortly after Correction of Hypercortisolism J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2747 - 2750. [Abstract] [Full Text] [PDF]

				L. D. Dorn, E. S. Burgess, T. C. Friedman, B. Dubbert, P. W. Gold, and G. P. Chrousos The Longitudinal Course of Psychopathology in Cushing's Syndrome after Correction of Hypercortisolism J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 912 - 919. [Abstract] [Full Text] [PDF]

				A. H. Tahir and L. R. Sheeler Recurrent Cushing's Disease After Transsphenoidal Surgery Arch Intern Med, May 1, 1992; 152(5): 977 - 981. [Abstract] [PDF]

				J. C. Melby Therapy of Cushing Disease: A Consensus for Pituitary Microsurgery Ann Intern Med, September 15, 1988; 109(6): 445 - 446. [Abstract] [PDF]